<doc>
  <docmeta id="113hr4475ih">
    <bill congress="113" type="hr" number="4475" version="ih"/>
    <revision size="5388" annotations="0" status="complete" id="4" commit-time="2014-04-30T22:44:06Z" committer="mbohmer" doc="113hr4475ih/4.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H179495C265634A20A469C4B6E895AF66" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 HR 4475 IH: Compassionate Freedom of Choice Act of 2014</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. House of Representatives</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-04-10</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>H. R. 4475</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20140410">April 10, 2014</action-date>
			<action-desc>
        <sponsor name-id="G000568">Mr. Griffith of Virginia</sponsor> (for himself and <cosponsor name-id="H001051">Mr. Hanna</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To allow the manufacture, importation, distribution, and sale of investigational drugs and devices
			 intended for use by terminally ill patients who execute an informed
			 consent document, and for other purposes.</official-title>
	</form>
	<legis-body id="HE05B1A379F7B4C93A4CEEBD339F1B619" style="OLC">
		<section id="H8662678E1FA848859AB8A05EA30687F5" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Compassionate Freedom of Choice Act of 2014" proposed="true">Compassionate Freedom of Choice Act of 2014</cato:entity-ref>
          </short-title>
        </quote>.</text>
		</section>
    <section id="H3014851AEA674AB3920FAA6AFEA5D295">
      <enum>2.</enum>
      <header>Drugs and devices for use by terminally ill patients</header>
      <text display-inline="no-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act">Federal Food, Drug, and Cosmetic Act</cato:entity-ref> is amended by inserting after <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:561">section 561</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/360bbb">21 U.S.C.
			 360bbb</cato:entity-ref>)</cato:entity> the following:</text>
			<quoted-block display-inline="no-display-inline" id="H12C03DFC99824EE993A0CCDE5823458E" style="OLC">
				<section id="H2EE2EADC8A7E4F57A00AE8288FE6C29A">
          <enum>561A.</enum>
          <header>Drugs and devices for use by terminally ill patients</header>
					<subsection id="HC7C3012F9BC14692A750EF396DC3482C">
            <enum>(a)</enum>
            <header>In general</header>
            <text display-inline="yes-display-inline">Nothing in this Act or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:351">section 351 of the Public Health Service Act</cato:entity-ref> prevents or restricts, and the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref> shall not implement or enforce any provision
			 of law preventing or restricting, the manufacture, importation,
			 distribution, or sale of an investigational drug or device intended for
			 use by a terminally ill patient in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:561A/ss:b" proposed="true">subsection (b)</cato:entity-ref>.</text>
					</subsection>
          <subsection id="H64F8C6DE2CA049B680DF1C772E7B6CA4">
            <enum>(b)</enum>
            <header>Patient requirements</header>
            <text display-inline="yes-display-inline">In order for an investigational drug or device to be intended for use in accordance with this
			 subsection, such drug or device must be intended for use by a patient who
			 has—</text>
						<paragraph id="H33EC5D613B1F4F49BE009FAC14B4ED2D">
              <enum>(1)</enum>
              <text display-inline="yes-display-inline">been diagnosed with a terminal illness by a licensed physician;</text>
						</paragraph>
            <paragraph id="H715D1572BBA043D5AEF812AC49B01201">
              <enum>(2)</enum>
              <text display-inline="yes-display-inline">been informed by a licensed physician that no drug or device that is lawfully marketed in the
			 United States is likely to cure the illness; and</text>
						</paragraph>
            <paragraph id="HC64C1224E9AF47F6A8603534ED0BD921">
              <enum>(3)</enum>
              <text>executed a written informed consent document that states—</text>
							<subparagraph id="H2D362DCF159146A79D700C0B645BC4FC">
                <enum>(A)</enum>
                <text>the known and potential risks and benefits of such drug or device; and</text>
							</subparagraph>
              <subparagraph id="HB1F43EE8C3254881BC60E95800E01CFC">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">any indications of the illness for which a drug or device is lawfully marketed, or for which
			 treatment is otherwise available, in the United States.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <subsection id="HCC39993D77674D87AE6750A50791F91B">
            <enum>(c)</enum>
            <header>Prohibition on requiring the disclosure, collection, and reporting of certain information by Food
			 and Drug Administration</header>
						<paragraph id="H071FCA0B3A7B44F7A123061B0E9C3131">
              <enum>(1)</enum>
              <header>In general</header>
              <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Commissioner of Food and Drugs</cato:entity-ref> may not require the disclosure, collection, or reporting of—</text>
							<subparagraph id="H0350DD5D79E344FAAE612B1E94390AAD">
                <enum>(A)</enum>
                <text>any information related to the delivery, administration, or use of an investigational drug or
			 device pursuant to this section; or</text>
							</subparagraph>
              <subparagraph id="HCAEDFE7FD1B5463CB08D13A4C2B29B5F">
                <enum>(B)</enum>
                <text>any information related to the clinical outcomes experienced by a terminally ill patient supplied
			 an investigational drug or device pursuant to this section.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="H6C773D2E5A5D48B28F31E263A48C23CF">
              <enum>(2)</enum>
              <header>Exception</header>
              <text display-inline="yes-display-inline">Nothing in this subsection prevents the sponsor of a clinical trial from voluntarily disclosing,
			 collecting, or reporting information to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref>.</text>
						</paragraph>
          </subsection>
          <subsection id="HFA863D440FD445B78F79E1FE7FA3A2F8">
            <enum>(d)</enum>
            <header>Definition of investigational drug or device</header>
            <text display-inline="yes-display-inline">In this section, the term <term>investigational drug or device</term> means a drug or device that—</text>
						<paragraph id="H9A390AEAF130423E9F66234A3229D5A1">
              <enum>(1)</enum>
              <text display-inline="yes-display-inline">has not yet been approved, licensed, or cleared for commercial distribution under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505">section 505</cato:entity-ref>,
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:510/ss:k">510(k)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:515">515 of this Act</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:351">section 351 of the Public Health Service
			 Act</cato:entity-ref>, and cannot otherwise be lawfully marketed in the United States; and</text>
						</paragraph>
            <paragraph id="HBF15B86D987C41F6A9D7EAF9B2F92378">
              <enum>(2)</enum>
              <text>is or has been the subject of one or more clinical trials.</text>
            </paragraph>
          </subsection>
        </section>
        <after-quoted-block>.</after-quoted-block>
      </quoted-block>
		</section>
    <section commented="no" id="H16ACEB9DF7E147F6A3B27CE91E30D543">
      <enum>3.</enum>
      <header>Liability protection</header>
      <text display-inline="no-display-inline">The <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act">Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/301">
          <cato:entity-ref entity-type="uscode" value="usc/21/301/etseq">21 U.S.C. 301 et seq</cato:entity-ref>.</external-xref>)</cato:entity> is amended by inserting after
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:561A" proposed="true">section 561A</cato:entity-ref>, as inserted by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Compassionate Freedom of Choice Act of 2014/s:2" proposed="true">section 2 of this Act</cato:entity-ref>, the following:</text>
			<quoted-block id="HF23DFB79B2C445C982F65DC0212FD61F">
				<section commented="no" id="H4EA648F960074F10BCC83239D1E77936">
          <enum>561B.</enum>
          <header>Liability protection</header>
          <text display-inline="no-display-inline">Except in the case of gross negligence or willful misconduct, any person who manufactures, imports,
			 distributes, prescribes, dispenses, or administers an investigational drug
			 or device in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:561A" proposed="true">section 561A</cato:entity-ref> shall not be liable in any
			 action under Federal or State law for any loss, damage, or injury arising
			 out of, relating to, or resulting from—</text>
					<paragraph commented="no" id="H5AC299554B264CBA8F20EE1013B54C93">
            <enum>(1)</enum>
            <text>the design, development, clinical testing and investigation, manufacturing, labeling, distribution,
			 sale, purchase, donation, dispensing, prescription, administration, or use
			 of the drug or device; or</text>
					</paragraph>
          <paragraph commented="no" id="H5CF0E58F446A421FB7A094B7B6C94EEB">
            <enum>(2)</enum>
            <text>the safety or effectiveness of the drug or device.</text>
          </paragraph>
        </section>
        <after-quoted-block>.</after-quoted-block>
      </quoted-block>
		</section>
  </legis-body>
</bill>
</doc>